| Age sex, Rai stage, total WBC count (cumm3) | % cells CD38+ | Zap-70 status | Specimen |
---|---|---|---|---|
Normal CD19+ B cells | Â | Â | Â | B1 |
 |  |  | B2 | |
 |  |  | B3 | |
 |  |  | B4 | |
 |  |  | B5 | |
U-CLL | 67Â M, stage II, 40,000 | 0Â % | neg | CLL6 |
88Â M, stage III, 90,000 | 59Â % | pos | CLL9 | |
62Â M, stage I, 96,000 | 24Â % | pos | CLL25 | |
71Â M, stage II, 135,000 | 8Â % | pos | CLL28 | |
56Â M, stage II, 102,000 | 55Â % | pos | CLL40 | |
68Â M, stage IV, 320,000 | 50Â % | pos | CLL44 | |
M-CLL | 55Â M, stage III, 37,000 | 0Â % | ND | CLL26 |
61Â M, stage 0, 24,000 | 5Â % | neg | CLL32 | |
64Â M, stage I, 28,000 | 0Â % | pos | CLL37 | |
78Â M, stage III, 98,000 | 0Â % | neg | CLL39 |